Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory gMG”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Large-scale testing (Phase 3)Study completedNCT06764160
What this trial is testing

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG

Who this might be right for
Generalized Myasthenia Gravis (gMG)Refractory gMG
Alexion Pharmaceuticals, Inc. 15
Large-scale testing (Phase 3)Study completedNCT02301624
What this trial is testing

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 117
Very early researchWithdrawnNCT06419166
What this trial is testing

An Exploratory Clinical Study of GC012F Injection for Refractory gMG

Who this might be right for
Refractory Generalized Myasthenia Gravis
Zhejiang University
Early research (Phase 1)Not Yet RecruitingNCT06759948
What this trial is testing

An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Chongbo Zhao 18
Large-scale testing (Phase 3)Study completedNCT03759366
What this trial is testing

Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Who this might be right for
Myasthenia GravisMyasthenia Gravis, Juvenile FormMyasthenia Gravis, Generalized
Alexion Pharmaceuticals, Inc. 12
Early research (Phase 1)Looking for participantsNCT06220201
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Who this might be right for
Multiple SclerosisMyasthenia Gravis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 120
Testing effectiveness (Phase 2)Ended earlyNCT00727194
What this trial is testing

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 14
Large-scale testing (Phase 3)Study completedNCT01997229
What this trial is testing

Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 125
Very early researchLooking for participantsNCT07058298
What this trial is testing

GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Daishi Tian 6